A9607 HCPCS Level II code: Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie

A9607 is the HCPCS code for “Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

A9607

Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie

Short description: Lutetium lu 177 vipivotide

HCPCS · United States

Medicare details

The indicators CMS publishes with A9607 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Other carrier priced
ASC
Approved for ambulatory surgical centers
Type of service
Therapeutic radiology
BETOS category
Standard imaging - nuclear medicine
Added
Oct 1, 2022

Where A9607 sits

  1. 1A codesAmbulance, supplies and miscellaneous
  2. 2Active code A9607Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code A9607 mean?

A9607 is the HCPCS code for “Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover A9607?

CMS lists A9607’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.